Deacetylravidomycin M, a new inhibitor of IL-4 signal transduction, produced by Streptomyces sp. WK-6326. I. Taxonomy, fermentation, isolation and biological activities. (Q48737653)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Deacetylravidomycin M, a new inhibitor of IL-4 signal transduction, produced by Streptomyces sp. WK-6326. I. Taxonomy, fermentation, isolation and biological activities.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11560373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Deacetylravidomycin M, a new inhibitor of IL-4 signal transduction, produced by Streptomyces sp. WK-6326. I. Taxonomy, fermentation, isolation and biological activities (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11560373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

4-[(2S,3R,4S,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]-1-hydroxy-10,12-dimethoxy-8-methylnaphtho[1,2-c]isochromen-6-one

1 reference

Deacetylravidomycin M

1 reference

Desacetylravidomycin

1 reference

4-[(3S,4R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]-8-ethenyl-1-hydroxy-10,12-dimethoxynaphtho[1,2-c]isochromen-6-one

1 reference

8

object named as

Omura S

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

author name string

M Arai

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11560373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

H Tomoda

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11560373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A Matsumoto

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11560373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Y Takahashi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11560373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

B H Woodruff

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11560373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

N Ishiguro

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11560373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

S Kobayashi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11560373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

S Omura

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11560373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

2001

1 reference

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/antibiotics1968/54/7/54_7_554/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.54.554?email=unpaywall_01@example.com

The Journal of Antibiotics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11560373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

54

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11560373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11560373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

554-561

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11560373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

online access status

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.54.554?email=unpaywall_01@example.com

access restriction status

1 reference

based on heuristic

inferred from online access status

Antitumor agents from Streptomyces anandii: gilvocarcins V, M and E.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.54.554

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.34.1544

The effects of gilvocarcin V and ultraviolet radiation on pBR322 DNA and lymphocytes

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.54.554

Antitumor activity of chrysomycins M and V

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.54.554

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.42.1446

Wavelength dependence for the induction of bacteriophage lambda by antitumor agent gilvocarcin V

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.54.554

Biochemical characterisation of elsamicin and other coumarin-related antitumour agents as potent inhibitors of human topoisomerase II.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.54.554

Studies on the mechanism of action of ravidomycin (AY-25,545)

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.54.554

Light-induced modifications of DNA by gilvocarcin V and its aglycone

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.54.554

Distribution of menaquinones in actinomycetes and corynebacteria

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.54.554

Chemical modification of ravidomycin and evaluation of biological activities of its derivatives

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.54.554

Light-dependent activity of the antitumor antibiotics ravidomycin and desacetylravidomycin

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.54.554

Deacetylravidomycin M, a new inhibitor of IL-4 signal transduction, produced by Streptomyces sp. WK-6326. II. Structure elucidation

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.54.554

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.54.554

Activation of Antitumor Agent Gilvocarcins by Visible Light

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.54.554

Deacetylravidomycin N-oxide, a new antibiotic. Taxonomy and fermentation of the producing organism and isolation, structure and biological properties of the antibiotic.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.54.554

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.42.347

An interleukin-4-induced transcription factor: IL-4 Stat

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.54.554

Khafrefungin, a novel inhibitor of sphingolipid synthesis

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.54.554

Molecular and cellular biology of mast cells and basophils

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.54.554

Ravidomycin (AY-25,545), a new antitumor antibiotic.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.54.554

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.36.355

New ravidomycin analogues, FE35A and FE35B, apoptosis inducers produced by Streptomyces rochei

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.54.554

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.51.1105

Identifiers

10.7164/ANTIBIOTICS.54.554

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11560373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11560373%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48737653&oldid=2256528786"